# Section II: 510(k) Summary

# 510(k) Summary

# Introduction

According to the requirements of 21 CFR 807.92, the following information provides sufficient detail to understand the basis for a determination of substantial equivalence.

# Submitter name, address, contact

Roche Diagnostics Corporation 9115 Hague Road Indianapolis, IN 46250

Contact Person: Sarah Baumann   
Phone: 317-521-3952   
Fax: 317-521-2324   
Email: sarah.baumann@roche.com Secondary Contact: Stephanie Greeman Phone: 317-521-2458   
Fax: 317-521-2324   
Email: stephanie.greeman@roche.com

Date Prepared: May 14, 2012

# 510(k) Summary, Continued

Device name Proprietary Name:

(1) cobas® b 123 POC System ) cobas® b 123 AutoQC Pack Tri-Level (3) cobas® b 123 AutoCVC Pack (4) Roche COMBITROL PLUS B

Common Name:

(1) Blood gas analyzer 2) AutoQC Pack Tri-Level ) AutoCVC Pack (4) COMBITROL PLUS B

<table><tr><td rowspan=1 colspan=1>Analyte</td><td rowspan=1 colspan=1>Classification Name</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>ProductCode</td></tr><tr><td rowspan=1 colspan=1>PCO2, PO2, pH</td><td rowspan=1 colspan=1>Blood gases (PCO2, PO2) and bloodpH test system</td><td rowspan=1 colspan=1>21 CFR § 862.1120</td><td rowspan=1 colspan=1>CHL</td></tr><tr><td rowspan=1 colspan=1>Na (sodium)</td><td rowspan=1 colspan=1>Sodium test system</td><td rowspan=1 colspan=1>21 CFR § 862.1665</td><td rowspan=1 colspan=1>JGS</td></tr><tr><td rowspan=1 colspan=1>K* (potassium)</td><td rowspan=1 colspan=1>Potassium test system</td><td rowspan=1 colspan=1>21 CFR § 862.1600</td><td rowspan=1 colspan=1>CEM</td></tr><tr><td rowspan=1 colspan=1>$Ca^{ }(Calcium)</td><td rowspan=1 colspan=1>Calcium test system</td><td rowspan=1 colspan=1>21CFR § 862.1145</td><td rowspan=1 colspan=1>JFP</td></tr><tr><td rowspan=1 colspan=1>Hct (Hematocrit)</td><td rowspan=1 colspan=1>Automated hematocrit instrument</td><td rowspan=1 colspan=1>21CFR § 864.5600</td><td rowspan=1 colspan=1>GGKF</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>Glucose test system</td><td rowspan=1 colspan=1>21 CFR § 862.1345</td><td rowspan=1 colspan=1>CGA</td></tr><tr><td rowspan=1 colspan=1>Lactate</td><td rowspan=1 colspan=1>Lactic acid test system</td><td rowspan=1 colspan=1>21 CFR § 862.1450</td><td rowspan=1 colspan=1>KHP</td></tr><tr><td rowspan=1 colspan=1>tHb</td><td rowspan=1 colspan=1>Whole blood hemoglobin assays(tHb)</td><td rowspan=1 colspan=1>21 CFR § 864.7500</td><td rowspan=1 colspan=1>KHG</td></tr><tr><td rowspan=1 colspan=1>O2Hb</td><td rowspan=1 colspan=1>Whole blood hemoglobin assays(Oxyhemoglobin)</td><td rowspan=1 colspan=1>21 CFR § 864.7500</td><td rowspan=1 colspan=1>GGZ</td></tr><tr><td rowspan=1 colspan=1>HHb</td><td rowspan=1 colspan=1>Deoxyhemoglobin</td><td rowspan=1 colspan=1>21 CFR § 864.7500</td><td rowspan=1 colspan=1>GKA</td></tr><tr><td rowspan=1 colspan=1>MetHb</td><td rowspan=1 colspan=1>Methemoglobin</td><td rowspan=1 colspan=1>21 CFR § 864.5620</td><td rowspan=1 colspan=1>KHG</td></tr><tr><td rowspan=1 colspan=1>SO2</td><td rowspan=1 colspan=1>Oxygen Saturation</td><td rowspan=1 colspan=1>870.1230 Oximeter</td><td rowspan=1 colspan=1>GLY</td></tr><tr><td rowspan=1 colspan=1>COHb (carboxyhemoglobin)</td><td rowspan=1 colspan=1>Carboxyhemoglobin assay</td><td rowspan=1 colspan=1>21 CFR § 864.7425</td><td rowspan=1 colspan=1>GHS</td></tr><tr><td rowspan=1 colspan=1>cobas b 123 AutoQC PackTri-Level.cobas b 123 AutoCVC PackRoche COMBITROL PLUS B</td><td rowspan=1 colspan=1>Quality control material(assayed and unassayed)</td><td rowspan=1 colspan=1>21 CFR § 862.1660</td><td rowspan=1 colspan=1>JJY</td></tr></table>

# 510(k) Summary, Continued

# Device description

# (1) cobas b 123 POC System:

The cobas b 123 POC system consists of a modular analyzer incorporating a Linux-based graphical user interface with a large color touch screen interfacing the analyzer electronic, sensor, fluidic and AutoQC modules. The user interface module contains the analyzer CPU and all required electronic interfaces for external communication, data storage and data transfer.

A single electrochemical sensor system independent of the reagent delivery system that utilizes Roche thick film technology consolidates the following analytes:

EY $\mathsf { p C O } _ { 2 }$ pH, calcium, potassium and sodium   
(potentiometric measurement)   
${ \mathfrak { p } } { \mathrm { O } } _ { 2 }$ (amperometric measurement)   
Hct (conductivity measurement)   
Glucose and Lactate enzyme reaction (amperometric   
measurement)

An optionally integrated oximeter module consisting of a spectrometer, measurement and calibration light source, respectively, an ultrasonic hemolyzer and thermostatic components measure $\mathrm { S O } _ { 2 }$ tHb, $\mathrm { O } _ { 2 } \mathrm { H b }$ , HHb, COHb, and MetHb.

A disposable, self-contained sample and reagent delivery system contains:

Liquid reagents, calibrators and waste container, stable   
for 42 days on-board   
Built-in safety shielded sample port   
Built-in oximeter cuvette   
Two peristaltic pump fluidics system   
Built-in air filter

The system also includes an optional integrated AutoQC module which utilizes a disposable cassette containing three levels of quality control material.

A smart memory chip is incorporated into each biosensor, reagent pack (sample and reagent delivery system) and AutoQC cassette providing the lot number, expiration date and value assignments (for QC and CVC materials). The chip also tracks and monitors sensor, reagent pack, AutoQC and AutoCVC cassette usage.

# (assayed and unassayed) (continued)

(2) cobas b 123 AutoQC Pack Tri-Level:

The cobas b 123 AutoQC pack Tri-Level contains 24 single glass ampoules of multi-analyte controls in 3 levels:

Level 1: representing concentrations of a patient's respiratory acidosis as given by low pH and high $\mathrm { P C O } _ { 2 }$ values, low $\mathrm { P O } _ { 2 } ,$ low values for $\ N a ^ { \mp } , K ^ { ^ { + } }$ , and tHb, normal values for glucose and high values for Hct, $\mathrm { i } \mathrm { C a } ^ { 2 + }$ and lactate.

Level 2: representing concentrations of normal values for all parameters except glucose, which is low.

Level 3: representing concentrations of a patient's respiratory alkalosis as given by high pH and low $\mathbf { P C O } _ { 2 }$ values, high ${ \bf P } { \bf O } _ { 2 }$ , high values for ${ \mathrm { N } } { \bar { \mathbf { a } } } ^ { + }$ , $\mathrm { K } ^ { + }$ , tHb, and glucose, and low values for Hct, $\mathrm { i C a } ^ { \sum + }$ EY and lactate.

# (3) cobas® b 123 AutoCVC Pack:

The cobas b 123 AutoCVC pack contains 24 single glass ampoules of multi-analyte controls in 6-levels covering the range of instrument performance. The CVC materials are an aqueous-based solution of salts, organic and carbonate buffers and metabolites equilibrated with predetermined levels of oxygen, carbon dioxide, nitrogen and dyes.

(4) Roche COMBITROL PLUS B:

COMBITROL PLUS B multi-analyte controls are available in 3 levels:

Level 1: representing concentrations of a patient's respiratory acidosis as given by low $\mathsf { p H }$ and high $\mathbf { P C O } _ { 2 }$ values, low $\mathrm { P O } _ { 2 }$ , low values for $\ N a ^ { \mp } , K ^ { \mp }$ , and $\operatorname { t H b }$ , normal values for glucose and high values for Hct, $\mathrm { i } \mathrm { C a } ^ { 2 + }$ , urea/BUN and lactate.

Level 2: representing concentrations of normal values for all parameters except glucose, which is low.

Level 3: representing concentrations of a patient's respiratory alkalosis as given by high $\mathfrak { p H }$ and low $\mathrm { P C O } _ { 2 }$ values, high $\mathrm { P O } _ { 2 }$ ,high values for ${ \ifmmode \mathbf { N } \mathbf { a } } ^ { + }$ , $\mathrm { K } ^ { + }$ , tHb, and glucose, and low values for Hct, $\mathrm { i } \mathrm { C a } ^ { \Sigma + }$ lactate and urea/BUN.

# 510(k) Summary, Continued

# Intended use

# (1) cobas b 123 POC System:

The cobas b 123 POC system is a fully automated POC system for whole blood in vitro measurement of $\mathsf { p H }$ , blood gases (BG), electrolytes $\mathbf { N a } ^ { + }$ $\mathsf { K } ^ { + }$ , $\mathrm { i } \mathrm { C a } ^ { 2 + }$ (ISE), hematocrit $( \mathrm { H c t } )$ , metabolites (Glu, Lac), total hemoglobin (tHb), hemoglobin derivatives $( \mathrm { O } _ { 2 } \mathrm { H } \mathrm { b }$ , HHb, COHb, MetHb), and oxygen saturation $( \mathrm { S O } _ { 2 } )$ . In addition, the cobas b 123 POC system calculates derived parameters.

It is dedicated for use in a Point-of-Care environment and laboratory. The integrated AutoQC module and the oximeter module are available as an option.

Depending on the equipment configuration of the instrument, the Sensor Cartridge and the Fluid Pack used, the following parameters are measured in human whole blood and QC materials (Table 1):

Table 1. Versions of the cobas b 123 POC System   

<table><tr><td rowspan=1 colspan=1>Instrument Version</td><td rowspan=1 colspan=1>Measured Parameters</td><td rowspan=1 colspan=1>Optional Modules</td></tr><tr><td rowspan=1 colspan=1>cobas b 123 &lt;1&gt; System</td><td rowspan=1 colspan=1>pH, BG (pO2, pCO2), ISE (Na*, K*,Ca^{²), Hct, Glu, Lac</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>cobas b 123 &lt;2&gt; System</td><td rowspan=1 colspan=1>pH, BG (pO2, pCO2), ISE (Na*, K*,Ca2²), Hct, Glu, Lac</td><td rowspan=1 colspan=1>AutoQC Module</td></tr><tr><td rowspan=1 colspan=1>cobas b 123 &lt;3&gt; System</td><td rowspan=1 colspan=1>pH, BG (pO2, pCO2), ISE (Na*, K+,Ca2*), Hct, Glu, Lac, tHb, OHb, HHb,COHb, MetHb, SO2</td><td rowspan=1 colspan=1>Oximeter Module</td></tr><tr><td rowspan=1 colspan=1>cobas b 123 &lt;4&gt; System</td><td rowspan=1 colspan=1>pH, BG (pO2, pCO2), ISE (Na*, K*,Ca²*), Hct, Glu, Lac, tHb, OHb, HHb,COHb, MetHb, SO2</td><td rowspan=1 colspan=1>AutoQC ModuleandOximeter Module</td></tr></table>

# (2) cobas b 123 AutoQC Pack Tri-Level:

The cobas b 123 AutoQC pack Tri-Level is a multi-analyte control intended for use as control material to monitor the measurement of $\mathsf { p H }$ $\mathrm { P C O } _ { 2 }$ , $\mathrm { P O } _ { 2 }$ , $\mathrm { S O } _ { 2 }$ , ${ \mathrm { N a } } ^ { + }$ , $\mathrm { K } ^ { + }$ , $\mathrm { i } \mathrm { C a } ^ { 2 + }$ , Hct, tHb and Hb derivatives as well as glucose and lactate on cobas b 123 systems with an AutoQC module.

# 510(k) Summary, Continued

# (3) cobas® b 123 AutoCVC Pack:

The cobas b 123 AutoCVC pack is a multi-analyte control, intended for use in calibration verification of the measuring range established by the cobas b 123 POC system for $\mathsf { p H }$ , $\mathrm { P C O } _ { 2 }$ $\mathrm { P O } _ { 2 }$ $\mathrm { S O } _ { 2 }$ , Nat, K+, $\mathrm { i } \dot { \mathsf { C a } } ^ { 2 + }$ , Hct, tHb and Hb derivatives as well as glucose and lactate on cobas b 123 systems with an AutoQC module.

# (4) Roche COMBITROL PLUS B:

COMBITROL PLUS B is a multi-analyte control intended for use as control material to monitor the measurement of $\mathfrak { p H }$ $\mathrm { P C O } _ { 2 }$ $\mathrm { P O } _ { 2 }$ , $\mathbb { S } 0 _ { 2 }$ Na+, $\dot { \mathsf { K } } ^ { + }$ ,Cr, $\mathrm { i } \mathrm { C a } ^ { 2 + }$ , Hct, tHb and Hb derivatives as well as glucose, lactate, urea/BUN and bilirubin on Roche OMNI S or cobas b 221 analyzers with an oximeter module, and cobas b 123 analyzers (except urea/BUN, chloride, and bilirubin). COMBITROL PLUS B control material is not intended for use with-analyzers from other manufacturers.

# Confidential

# 510(k) Summary, Continued

# Predicate devices

The cobas b 123 POC System is substantially equivalent to other products in commercial distribution intended for similar use. We claim equivalency to the following currently marketed products:

• cobas b 221 (OMNI S) Blood Gas System—K032311   
• Hitachi 902 Analyzer (Glucose and Lactate)—K921661   
• cobas c 501 Analyzer (Glucose and Lactate)-K060373/A001   
• COMBITROL PLUS B / AUTOTROL PLUS B—K032453

# 510(k) Summary, Continued

# Substantial equivalence

The cobas b 123 POC System is substantially equivalent to other devices legally marketed in the United States.

The cobas b 123 POC System is substantially equivalent to the cobas b 221 (OMNI S Analyzer), cleared on K032311, for the following parameters:

• pH • K+ • O2Hb SO2 • pO2 • iCa^{+ • HHb • EY ${ \tt p C O } _ { 2 }$ EPY • Hct1 • COHb Na+ tHb • MetHb

The cobas b 123 POC system is substantially equivalent to the Roche Gluco-Quant Glucose/HK assay on the Hitachi 902 (K921661) and the Roche Glucose HK Assay on the cobas c 501 analyzer (K060373/A001) for the measurement of glucose.

The cobas b 123 POC system is substantially equivalent to the Roche Lactate assay on the Hitachi 902 analyzer (K921661) and the Lactate Generation 2 (Gen.2) assay on the cobas c 501 analyzer (K060373/A001) for the measurement of lactate. Per 21 CFR 862.1450, a Lactic Acid Test System is exempt to measure lactic acid in whole blood and plasma.

The cobas b 123 AutoQC Pack Tri-Level, cobas b 123 AutoCVC Pack, and COMBITROL PLUS B materials are substantially equivalent to the Roche AUTOTROL PLUS B and Roche COMBITROL PLUS B materials cleared on K032453.

# 510(k) Summary, Continued

Substantial equivalence comparison— similarities

Table 2 provides the similarities between the cobas b 123 POC System (K111188) and the cobas b 221 predicate device (K032311).

Table 2. Comparison of Candidate (cobas b 123) and Predicate (cobas b 221) Devices—Similarities   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 POC System(K111188)</td><td rowspan=1 colspan=1>Predicate Devicecobas b 221(K032311)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The cobas b 123 POC system is a fully automatedPOC system for whole blood in vitro measurementof pH, blood gases (BG), electrolytes Na*, K*, iCa2+(ISE), hematocrit (Hct), metabolites (Glu, Lac), totalhemoglobin (tHb), hemoglobin derivatives (O2Hb,HHb, COHb, MetHb), and oxygen saturation (SO2).In addition, the cobas b 123 POC system calculatesderived parameters.It is dedicated for use in a Point-of-Careenvironment and laboratory. The integrated AutoQCmodule and the oximeter module are available as anoption.Depending on the equipment configuration of theinstrument, the Sensor Cartridge and the Fluid Packused, the following parameters are measured inhuman whole blood and QC materials. See Table 1(page 5).</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Blood GasMeasurement</td><td rowspan=1 colspan=1>pH and pCO2 by potentiometrypO2 by amperometry</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>ElectrolyteMeasurement</td><td rowspan=1 colspan=1>K*, Na*, iCa2²+ by potentiometry</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>MetaboliteMeasurement</td><td rowspan=1 colspan=1>Glucose and Lactate by amperometry</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary, Continued

# Substantial equivalence comparison— similarities (continued)

Table 2 provides the similarities between the cobas b 123 POC System (K111188) and the cobas b 221 predicate device (K032311).

Table 2. Comparison of Candidate (cobas b 123) and Predicate (cobas b 221) Devices—Similarities, cont.   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 POC System(K111188)</td><td rowspan=1 colspan=1>Predicate Devicecobas b 221(K032311)</td></tr><tr><td rowspan=1 colspan=1>HemoglobinMeasurement</td><td rowspan=1 colspan=1>tHb, SO2, O2Hb, HHb, COHb, MetHb:Spectrophotometric</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>HematocritMeasurement</td><td rowspan=1 colspan=1>Conductivity</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Sensor Technology</td><td rowspan=1 colspan=1>Amperometric and potentiometric thick filmmicroelectrode array technology forGlucose and Lactate</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>SampleIntroduction</td><td rowspan=1 colspan=1>Syringe and capillary aspiration</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>On-Board(In-Use) ReagentStability</td><td rowspan=1 colspan=1>Up to 42 days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reagent Tracking</td><td rowspan=1 colspan=1>Memory chip technology for identification,lot specifications, usage tracking andtraceability allowing pack to be moved fromone system to another</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>QC Material</td><td rowspan=1 colspan=1>COMBITROL PLUS B (manual QC) andAUTOTROL PLUS B (automated QC)</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibration</td><td rowspan=1 colspan=1>Two-point liquid calibration</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Graphical UserInterface</td><td rowspan=1 colspan=1>Menu-driven touch screen</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>AdditionalAnalyzer Hardware</td><td rowspan=1 colspan=1>Hard drive and printer</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Operating SystemSoftware</td><td rowspan=1 colspan=1>Linux-based</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>System OperatingTemperature</td><td rowspan=1 colspan=1>15-32°C</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary, Continued

# Substantial equivalence comparison-- similarities (continued)

Table 3 provides the similarities between the cobas b 123 POC System (K111188) and the following predicate devices:

Roche Glucose HK Assays (K921661 and K060703/A001) Roche Lactate Assays (K921661 and K060703/A001)

Table 3. Comparison of Candidate and Predicate Devices for Glucose and Lactate Measurement—Similarities   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 POC System(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche Hitachi Glucose HK Assays:Hitachi 902 (K921661) andcobas c 501 (K060373/A001)</td></tr><tr><td rowspan=1 colspan=1>Test Principle</td><td rowspan=1 colspan=1>Enzymatic</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=3>:•</td></tr><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 POC System(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche Hitachi Lactate Assays:Hitachi 902 (K921661) andcobas c 501 (K060373/A001)</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Whole blood</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Test Principle</td><td rowspan=1 colspan=1>Enzymatic</td><td rowspan=1 colspan=1>Same</td></tr></table>

# Confidential

# 510(k) Summary, Continued

# Substantial equivalence comparison similarities (continued)

Table 4 provides the similarities between the cobas b 123 AutoQC Pack Tri-Level quality control materials (K111188) and the predicate device, Roche AUTOTROL PLUS B (K032453).

Table 4. Comparison of Candidate and Predicate Devices (AutoQC Materials)— Similarities   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 AutoQC Pack Tri-Level(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche AUTOTROL PLUS B(K032453)</td></tr><tr><td rowspan=1 colspan=1>Number ofLevels</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Buffered, aqueous electrolyte solutionequilibrated with carbon dioxide and oxygengas mixture</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>TechnologicalCharacteristics</td><td rowspan=1 colspan=1>The material consists of buffered aqueouselectrolyte solutions with clinically relevantconcentrations of the targeted analytes,tonometered with precision gas mixtures ofcarbon dioxide and oxygen to achieve pHand blood gas values that span the range ofvalues typical for such products with thesame intended use. A mixture of dyes is usedto simulate absorbance of hemoglobinderivatives. Hematocrit is simulated byconductivity.</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary, Continued

# Substantial equivalence comparison— similarities (continued)

Table 5 provides the similarities between the modified Roche COMBITROL PLUS B quality control material (K111188) and the predicate device, Roche COMBITROL PLUS B (K032453).

Table 5. Comparison of Candidate and Predicate Devices (COMBITROL PLUS B)—Similarities   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate DeviceModified COMBITROL PLUS B(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche COMBITROL PLUS B(K032453)</td></tr><tr><td rowspan=1 colspan=1>Number ofLevels</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Fill Volume</td><td rowspan=1 colspan=1>1.7 mL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Buffered, aqueous electrolyte solutionequilibrated with carbon dioxide and oxygengas mixture</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>TechnologicalCharacteristics</td><td rowspan=1 colspan=1>The material consists of buffered aqueouselectrolyte solutions with clinically relevantconcentrations of the targeted analytes,tonometered with precision gas mixtures ofcarbon dioxide and oxygen to achieve pHand blood gas values that span the range ofvalues typical for such products with thesame intended use. A mixture of dyes is usedto simulate absorbance of hemoglobinderivatives. Hematocrit is simulated byconductivity.</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary, Continued

# Substantial equivalence comparison— similarities (continued)

Table 6 provides the similarities between the cobas b 123 AutoCVC Pack (K11 1 188) and the predicate device, Roche AUTOTROL PLUS B (K032453).

Table 6. Comparison of Candidate and Predicate Devices (CVC Materials)— Similarities   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 AutoCVC Pack(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche AUTOTROL PLUS B(K032453)</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Buffered, aqueous electrolyte solutionequilibrated with carbon dioxide and oxygengas mixture</td><td rowspan=1 colspan=1>Same.</td></tr><tr><td rowspan=1 colspan=1>TechnologicalCharacteristics</td><td rowspan=1 colspan=1>The material consists of buffered aqueouselectrolyte solutions with clinically relevantconcentrations of the targeted analytes,tonometered with precision gas mixtures ofcarbon dioxide and oxygen to achieve pHand blood gas values that span the range ofvalues typical for such products with thesame intended use. A mixture of dyes is usedto simulate absorbance of hemoglobinderivatives. Hematocrit is simulated byconductivity.</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 510(k) Summary, Continued

Substantial equivalence comparison differences

Table 7 provides the differences between the cobas b 123 POC System (K111188) and the cobas b 221 predicate device (K032311).

Table 7. Comparison of Candidate (cobas b 123) and Predicate (cobas b 221) Devices—Differences   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 POC System(K111188)</td><td rowspan=1 colspan=1>Predicate Devicecobas b 221(K032311)</td></tr><tr><td rowspan=1 colspan=1>Sample Volume</td><td rowspan=1 colspan=1>123 μl</td><td rowspan=1 colspan=1>210 μl</td></tr><tr><td rowspan=1 colspan=1>Electrochemicalsensors</td><td rowspan=1 colspan=1>pH, PO2, PCO2, K*, Na*, iCa24, Glucose,Reference microelectrode array sensorwith up to 28 days in-use lifeNote: Sensors with Lactate are stable up to21 days.</td><td rowspan=1 colspan=1>pH, PO2, PCO2, K*, Na*, Cl,iCa²* Reference electrodes with6 to 16 months in-use life,depending on the electrode type.</td></tr><tr><td rowspan=1 colspan=1>Electrochemicalsensor storagestability</td><td rowspan=1 colspan=1>Sensor: 2°C - 8°C for 4 months</td><td rowspan=1 colspan=1>Sensor: 25°C for 18 or 24months, depending on electrodetype</td></tr><tr><td rowspan=1 colspan=1>Auto QCModule</td><td rowspan=1 colspan=1>AutoQC Module holds one AutoQC Pack,which is comprised of 24 AUTOTROLPLUS B tri-level ampoules.</td><td rowspan=1 colspan=1>QC module holds 120AUTOTROL PLUS B tri-levelampoules.</td></tr></table>

# 510(k) Summary, Continued

# Substantial equivalence comparison— differences (continued)

Table 8 provides the differences between the cobas b 123 POC System (K111188) and the Roche Glucose HK Assay predicate devices (K921661 and K060703/A001).

Table 8. Comparison of Candidate and Predicate Devices for Glucose Measurement-Differences   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 POC System(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche Hitachi Glucose HKAssays:Hitachi 902 (K921661) andcobas c 501 (K060373/A001)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The cobas b 123 POC system is a fullyautomated POC system for whole bloodin vitro measurement of pH, blood gases(BG), electrolytes Na*, K+, iCa2²+ (ISE),hematocrit (Hct), metabolites (Glu, Lac),total hemoglobin (tHb), hemoglobinderivatives (O2Hb, HHb, COHb, MetHb),and oxygen saturation (SO2).In addition, the cobas b 123 POC systemcalculates derived parameters.It is dedicated for use in a Point-of-Careenvironment and laboratory. Theintegrated AutoQC module and theoximeter module are available as anoption.Depending on the equipmentconfiguration of the instrument, theSensor Cartridge and the Fluid Pack used,the following parameters are measured inhuman whole blood and QC materials.See Table 1 (page 5).</td><td rowspan=1 colspan=1>Gluco-quant Glucose/HK Assay(Hitachi 902): Enzymatic in vitrotest for the quantitativedetermination of glucose in humanserum, plasma, urine and CSF onRoche automated clinicalchemistry analyzers.Glucose HK Assay(cobas c 501):In vitro test for the quantitativedetermination of glucose in humanserum, plasma, urine, CSF andhemolysate on Roche/Hitachicobas c systems.</td></tr><tr><td rowspan=1 colspan=1>Sample Type</td><td rowspan=1 colspan=1>Whole Blood</td><td rowspan=1 colspan=1>Serum, plasma, urine, CSF andhemolysate</td></tr></table>

# 510(k) Summary, Continued

# Substantial equivalence comparison— differences (continued)

Table 8 provides the differences between the cobas b 123 POC System (K111188) and the Roche Glucose HK Assay predicate devices (K921661 and K060703/A001).

Table 8. Comparison of Candidate and Predicate Devices for Glucose Measurement—Differences, cont.   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 POC System(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche Hitachi Glucose HK Assays:Hitachi 902 (K921661) andcobas c 501 (K060373/A001)</td></tr><tr><td rowspan=1 colspan=1>MeasurementPrinciple</td><td rowspan=1 colspan=1>Amperometric measurement of thedetectable product (H2O2) under apolarization voltage of 350 mV.</td><td rowspan=1 colspan=1>UV photometric measurement of thedetectable product (NADPH) at 340 nm.</td></tr></table>

# 510(k) Summary, Continued

# Substantial equivalence comparisondifferences (continued)

Table 9 provides the differences between the cobas b 123 POC System (K111188) and the Roche Lactate Assay predicate devices (K921661 and K060703/A001).

Table 9. Comparison of Candidate and Predicate Devices for Lactate Measurement—Differences   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 POC System(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche Hitachi Lactate Assays:Hitachi 902 (K921661) andcobas c 501 (K060373/A001)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The cobas b 123 POC system is a fullyautomated POC system for whole bloodin vitro measurement of pH, bloodass (BG electrolytes NaK(ISE), hematocrit (Hct), metabolites(Glu, Lac), total hemoglobin (tHb),hemoglobin derivatives (O2Hb, HHb,COHb, MetHb), and oxygen saturation(SO2). In addition, the cobas b 123POC system calculates derivedparameters.It is dedicated for use in a Point-of-Careenvironment and laboratory. Theintegrated AutoQC module and theoximeter module are available as anoption.Depending on the equipmentconfiguration of the instrument, theSensor Cartridge and the Fluid Packused, the following parameters aremeasured in human whole blood andQC materials. See Table 1 (page 5).</td><td rowspan=1 colspan=1>Lactate Assay (Hitachi 902): For thequantitative determination ofL-Lactate in plasma, cerebrospinalfluid or whole blood onRoche/Hitachi automated clinicalchemistry analyzers. L-Lactatelevels that evaluate the acid-basestatus are used in the diagnosis andtreatment of lactic acidosis.Lactate Gen. 2 Assay(cobas c 501):In vitro test for the quantitativedetermination of lactate in humanplasma and CSF on Roche/Hitachicobas e systems.</td></tr><tr><td rowspan=1 colspan=1>MeasurementPrinciple</td><td rowspan=1 colspan=1>Amperometric measurement of thedetectable product (H2O2) under apolarization voltage of 350 mV.</td><td rowspan=1 colspan=1>UV photometric measurement of thedetectable product (chromogen) at340 nm.</td></tr></table>

# 510(k) Summary, Continued

# Substantial equivalence comparison— differences (continued)

Table 10 provides the differences between the cobas b 123 AutoQC Pack Tri-Level quality control materials (K111188) and the predicate device, Roche AUTOTROL PLUS B (K032453).

Table 10. Comparison of Candidate and Predicate Devices (AutoQC Materials)— Differences   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 AutoQC Pack Tri-Level(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche AUTOTROL PLUS B(K032453)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The cobas b 123 AutoQC packTri-Level is a multi-analyte controlintended for use as control material tomonitor the measurement of pH, pCO2,pO2, SO2, Na*, K+, iCa²*, Hct, tHb andHb derivatives as well as glucose andlactate on cobas b 123 systems with anAutoQC module.</td><td rowspan=1 colspan=1>AUTOTROL PLUS B, a Multi-analyte control, is intended for useas a control material to monitor themeasurement of pH, pCO2, pO2,SO2, Na*, K*, Cl, iCa2², Hct, tHband Hb derivatives as well asGlucose, Lactate, Urea/BUN andBilirubin on Roche OMNI S andcobas b 221 analyzers with anoximeter module. This controlmaterial is packaged for use with theAutoQC module, an option to theRoche OMNI S and cobas b 221analyzers. AUTO-TROL PLUS Bcontrol material is not intended to beused with analyzers from othermanufacturers.</td></tr><tr><td rowspan=1 colspan=1>Auto QC Pack</td><td rowspan=1 colspan=1>The AutoQC Pack is comprised of 24AUTOTROL PLUS B tri-levelampoules.The AutoQC Pack also contains a smartmemory chip for tracking andtraceability, allowing the pack to bemoved from one system to another.</td><td rowspan=1 colspan=1>The QC Pack holds 120AUTOTROL PLUS B tri-levelampoules.The QC Pack does not contain asmart memory chip.</td></tr><tr><td rowspan=1 colspan=1>Fill Volume</td><td rowspan=1 colspan=1>1.0 mL</td><td rowspan=1 colspan=1>1.7 mL</td></tr></table>

# 510(k) Summary, Continued

# Substantial equivalence comparison— differences (continued)

Table 11 provides the differences between the modified Roche COMBITROL PLUS B quality control material (K111188) and the predicate device, Roche COMBITROL PLUS B (K032453).

Table 11. Comparison of Candidate and Predicate Devices (COMBITROL PLUS B)—Differences   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate DeviceModified COMBITROL PLUS B(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche COMBITROL PLUS B(K032453)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>COMBITROL PLUS B is a multi-analyte control intended for use ascontrol material to monitor themeasurement of pH, PCO2, PO2, SO2,Na*, K†, Cl, iCa2*, Hct, tHb and Hbderivatives as well as glucose, lactate,urea/BUN and bilirubin on RocheOMNI S or cobas b 221 analyzers withan oximeter module, and cobas b 123analyzers (except urea/BUN, chloride,and bilirubin).COMBITROL PLUS B controlmaterial is not intended for use withanalyzers from other manufacturers.</td><td rowspan=1 colspan=1>COMBITROL PLUS B, a Multi-analyte control, is intended for useas control material to monitor themeasurement of pH, PCO2, PO2,SO2, Na*, K+, Cl, iCa², Hct, tHband Hb derivatives as well asglucose, lactate, urea/BUN andbilirubin on Roche OMNI S orcobas b 221 analyzers with anoximeter module..COMBITROL PLUS B controlmaterial is not intended for use withanalyzers from other manufacturers.</td></tr></table>

# 510(k) Summary, Continued

# Substantial equivalence comparison— differences (continued)

Table 12 provides the differences between the cobas b 123 AutoCVC Pack (K111188) and the predicate device, Roche AUTOTROL PLUS B (K032453).

Table 12. Comparison of Candidate and Predicate Devices (CVC Materials)— Differences   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Candidate Devicecobas b 123 AutoCVC Pack(K111188)</td><td rowspan=1 colspan=1>Predicate DeviceRoche AUTOTROL PLUS B(K032453)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>The cobas b 123 AutoCVC pack isa multi-analyte control, intended foruse in calibration verification of themeasuring range established by thecobas b 123 POC system for pH,PCO2, PO2, SO2, Na, K+,CHct, tHb and Hb derivatives as wellas glucose and lactate oncobas b 123 systems with anAutoQC module.</td><td rowspan=1 colspan=1>AUTOTROL PLUS B, a Multi-analytecontrol, is intended for use as a controlmaterial to monitor the measurement ofpH, pCO2, pO2, SO2, Na*, K, Cr, iCa²,Hct, tHb and Hb derivatives as well asGlucose, Lactate, Urea/BUN andBilirubin on Roche OMNI S andcobas b 221 analyzers with an oximetermodule. This control material ispackaged for use with the AutoQCmodule, an option to the Roche OMNI Sand cobas b 221 analyzers. AUTO-TROL PLUS B control material is notintended to be used with analyzers fromother manufacturers.</td></tr><tr><td rowspan=1 colspan=1>Indications forUse</td><td rowspan=1 colspan=1>The cobas b 123 AutoCVC Pack isan assayed control for use incalibration verification of themeasuring range established by thecobas b 123 POC system foranalytes listed in the package insert.</td><td rowspan=1 colspan=1>COMBITROL PLUS B / AUTOTROLPLUS B assayed controls are intendedto be used to monitor and evaluate theanalytical performance of the RocheOMNI S for analytes listed in thepackage insert.</td></tr><tr><td rowspan=1 colspan=1>Fill Volume</td><td rowspan=1 colspan=1>1.0 mL</td><td rowspan=1 colspan=1>1.7 mL</td></tr></table>

# Conclusion

The information provided in this Premarket Notification [510(k)] will support a determination of substantial equivalence for the cobas b 123 POC System.

Roche Diagnostics Corporation   
c/o Sarah Baumann   
Regulatory Affairs Consultant   
9115 Hague Road   
Indianapolis, IN 46250   
Re: k111188   
Trade Name: Cobas $^ \mathrm { \textregistered }$ b 123 POC System, Cobas $^ \mathrm { \textregistered }$ b 123 AutoQC Pack Tri-Level Cobas $^ \mathrm { \textregistered }$ b 123 AutoCVC Pack, Roche COMBITROL PLUS B   
Regulation Number:21 CFR $\ S 8 6 2 . 1 1 2 0$   
Regulation Name: Blood gases (PC02, PO2) and blood pH test system   
Regulatory Class: II   
Product Code: CHL, JGS, CEM, JFP, GKF, CGA, KHP, KHG, GGZ, GKA, GLY, GHS,   
JJY   
Dated May 9, 2012   
Received: May 10, 2012

Dear Ms. Baumann:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical   
Devices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance...

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm

Sincerely yours,

2

Coupney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use Form

510(k) Number (if known): K111188

Device Name: cobas® b 123 POC System

Indications for Use:

The cobas b 123 POC system is a fully automated POC system for whole blood in vitro measurement of pH, blood gases (BG), electrolytes $\mathbf { N a } ^ { + }$ $\dot { \mathsf { K } } ^ { + }$ $\mathsf { i C a } ^ { 2 + }$ (ISE), hematocrit (Hct), metabolites (Glu, Lac), total hemoglobin (tHb), hemoglobin derivatives $( { \mathrm { O } } _ { 2 } { \mathrm { H b } }$ HHb, COHb, MetHb), and oxygen saturation $( \mathsf { S O } _ { 2 } )$ . In addition, the cobas b 123 POC system calculates derived parameters.

It is dedicated for use in a Point-of-Care environment and laboratory. The integrated AutoQC module and the oximeter module are available as an option.

$\mathsf { p H }$ ${ \mathfrak { p O } } _ { 2 }$ and $\mathsf { p C O } _ { 2 } : \mathsf { p H }$ ${ \mathsf { p O } } _ { 2 }$ and ${ \mathsf { P C O } } _ { 2 }$ measurements are used in the diagnosis and treatment of life-threatening acid-base disturbances.

Sodium $( \mathsf { N a } ^ { + } )$ : sodium measurements are used in the diagnosis and treatment of aldosteronism, diabetes insipidus, adrenal hypertension, Addison's disease, dehydration, inappropriate antidiuretic secretion, or other diseases involving electrolyte imbalance.

Potassium $( \mathsf { K } ^ { + } )$ : potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels.

Calcium $( \mathsf { C a } ^ { 2 + } )$ : calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms).

Prescription Use _X Over-The-Counter Use AND/OR (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Oatl Chnn

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use Form

510(k) Number (if known): K111188

Device Name: cobas® b 123 POC System

Indications for Use, continued:

Hematocrit (Hct): hematocrit measurements are used to distinguish normal from abnormal states of whole blood, such as anemia and erythrocytosis (an increase in the number of red cells).

Glucose (Glu): glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus and idiopathic hypoglycemia, and of pancreatic. islet cell carcinoma.

Lactate (Lac): Lactate measurements are used to evaluate the acid-base status and are used in the diagnosis and treatment of lactic acidosis (abnormally high acidity of the blood.)

Total Hemoglobin (tHb): total hemoglobin measurements are used to measure the hemoglobin content of whole blood for the detection of anemia.

${ \sf O } _ { 2 } { \sf H } { \sf b }$ : oxyhemoglobin as a fraction of total hemoglobin.

COHb: carboxyhemoglobin measurements are used to determine the carboxyhemoglobin content of human blood as an aid in the diagnosis of carbon monoxide poisoning.

MetHb: methemoglobin as a fraction of total hemoglobin.

HHb: reduced hemoglobin as a fraction of total hemoglobin.

EY $\dot { \mathsf { S } } \dot { \mathsf { O } } _ { 2 }$ : oxygen saturation, more specifically the ratio between the concentration of oxyhemoglobin and oxyhemoglobin plus reduced hemoglobin.

Prescription Use _X Over-The-Counter Use (Part 21 CFR 801 Subpart D) AND/OR (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/fa98808c74af985a632743bf72890e19bcad20239a3c65af7e818ff660a848ff.jpg)

Division Sign-Off .   
Office of In Vitro Diagnostic Device Evaluation and Safety

# Indications for Use Form

510(k) Number (if known): K111188

Device Name: cobas® b 123 AutoQC Pack Tri-Level

Indications for Use:

The cobas b 123 AutoQC pack Tri-Level is a multi-analyte control intended for use as control material to monitor the measurement of $\mathfrak { p H }$ , $\mathbf { P C O } _ { 2 }$ $\mathsf { P O } _ { 2 }$ $\mathbf { S O } _ { 2 }$ , Na+, $\mathrm { K } ^ { + }$ , iCa2}, Hct, tHb and Hb derivatives as well as glucose and lactate on cobas b 123 systems with an AutoQC module.

# Device Name: cobas® b 123 AutoCVC Pack

Indications for Use:

The cobas b 123 AutoCVC Pack is a multi-analyte control, intended for use in calibration verification of the measuring range established by the cobas b 123 POC system for pH, $\mathbf { P C O } _ { 2 }$ , $\mathsf { P O } _ { 2 }$ , $\mathrm { S O } _ { 2 }$ , ${ { \ N a } ^ { + } }$ , $\bar { \mathsf { K } } ^ { + }$ , $\mathrm { i C a } ^ { 2 + }$ , Hct, tHb and Hb derivatives as well as glucose and lactate on cobas b 123 systems with an AutoQC module.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Rutl Ca

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use Form

510(k) Number (if known): K111188

Device Name: Roche COMBITROL PLUS B

Indications for Use:

COMBITROL PLUS B is a multi-analyte control intended for use as control material to monitor the measurement of $\mathfrak { p H }$ $\mathrm { P C O } _ { 2 } ,$ , $\mathrm { P O } _ { 2 }$ $\mathtt { S O } _ { 2 }$ , ${ \mathsf { N a } } ^ { + }$ $\mathbf { K } ^ { \dagger } .$ , Cr, $\mathrm { i } \mathrm { C a } ^ { 2 + }$ , Hct, tHb and Hb derivatives as well as glucose, lactate, urea/BUN and bilirubin on Roche OMNI S or cobas b 221 analyzers with an oximeter module, and cobas b 123 analyzers (except urea/BUN, chloride, and bilirubin). COMBITROL PLUS B control material is not intended for use with analyzers from other manufacturers.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)